Transdisciplinary Global Research in Rare CNS Tumors: A Framework to Impact Outcomes Across CNS Disease

SNO
9/25/20, 2:00 PM
America/New York GMT -4 summer

Description

Transdisciplinary Global Research in Rare CNS Tumors: A Framework to Impact Outcomes Across CNS Disease

 

Participating Centers: National Cancer Institute, National Institutes of Health; Erasmus MC Cancer Institute; Yale University and Brigham and Women's Hospital; Piedmont Healthcare; Cambridge Cancer Center, CRUK Cambridge Institute; Fred Hutchinson Cancer Research Center; Heidelberg University Hospital; The Jackson Laboratory

 

Overall learning goal: Increase awareness about the challenges of clinical care and research in CNS tumors and possible solutions.

 

By the end of this course, participants will be able to:

1. List challenges in creating preclinical models for CNS tumors that reliably recapitulate human disease.

2. List novel techniques in CNS tumor classification and their prognostic and/or therapeutic implications.

3. Identify challenges in clinical trial design and describe innovative methods applicable to patients with rare CNS tumors.

4. List ongoing initiatives to improve care and enhance research for patients with rare CNS tumors.

 

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Transdisciplinary Global Research in Rare CNS Tumors: A Framework to Impact Outcomes Across CNS Disease

Inglês

 

Speakers

Kenneth Aldape, Terri Armstrong, Martin van den Bent, Elizabeth B. Claus, Erin Dunbar, Mark Gilbert, Richard Gilbertson, Eric Holland, Marta Penas-Prado, Felix Sahm, Roel Verhaak

 

Link to the Event

Banner to the Event

Transdisciplinary Global Research in Rare CNS Tumors: A Framework to Impact Outcomes Across CNS Disease